India], July 28: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World ART (Assisted Reproductive ...

Also in today’s newsletter, EU warns Europe’s roads unfit for war, UBS currency derivatives and Botswana’s push on De Beers ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Designed by Sylvia Richards, the mass-timber addition to Adimab's Lebanon campus is sensitive to the lushly forested wetland ...

Shares in Asia are mostly higher after the U.S. and China ended their latest round of trade talks without a deal. U.S, ...

The ongoing Phase I/IIa study (NCT04725331) is a multicenter, open label, dose-escalation study evaluating BT-001 as a single agent and in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) ...

The deal, which focuses first on a COPD drug GSK believes holds “best-in-class” potential, could involve a dozen medicines ...

The Proteus Syndrome market is entering a pivotal decade, driven by increasing disease recognition, improving diagnostic techniques, development of genetic testing techniques and other innovative ...

Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ("BioInven ...

The 10th annual conference featured sessions on leadership, becoming invaluable at work and developing a legacy through ...

INBRAIN Neuroelectronics has announced promising interim results from the world's first human clinical study of its graphene-based brain-computer interface (BCI), marking a major leap forward in ...

New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.